• OTUD7B, SQSTM1/p62, and Antiviral Immunity

  2026-09-05

  The reference study identifies OTUD7B as a negative regulator of antiviral immunity that promotes selective autophagic degradation of IRF3 through SQSTM1/p62. Its key mechanistic advance is linking K63-linked deubiquitination of SQSTM1 at K7 to cargo-receptor oligomerization, IRF3 turnover, and feedback control of type I interferon signaling.

• 3X FLAG Peptide: Mechanism, Workflow, and Limits

  2026-09-04

  The 3X (DYKDDDDK) Peptide is a hydrophilic tandem FLAG epitope for recombinant-protein detection and purification. This article defines its antibody-binding mechanism, product-specific handling parameters, assay applications, and limits when interpreting mechanistic biology.

• Sodium Oxamate: LDH-A Workflow for Lactate Studies

  2026-09-04

  Use Sodium Oxamate as a water-compatible LDH-A perturbation tool for connecting glycolytic flux, lactate production, and tissue-repair phenotypes. Its value is greatest when metabolic readouts are paired with lactylation, cell-state, white-matter, or viability assays rather than interpreted as a single-pathway proof.

• MK-571: Reliable Viability & Inflammation Assays

  2026-09-03

  Learn how MK-571 (L-660,711) leukotriene D4 receptor antagonist, SKU B7023, can clarify leukotriene signaling and ABCC1/MRP1 effects in cell viability, cytotoxicity, macrophage, and pulmonary workflows. This scenario-based guide covers mechanism, solvent compatibility, controls, interpretation, and practical product-selection criteria.

• PD 0332991: CDK4/6 Assay Workflows

  2026-09-03

  Build reproducible cell-cycle, viability, and mechanistic assays around PD 0332991 (Palbociclib) HCl, with Rb-aware controls and time-resolved readouts. The workflow also shows how an ERCC1–p53 DNA-repair study can inform hypothesis-driven combination experiments without confusing cross-domain evidence with validated mechanism.

• Sulfo-NHS-Biotin for Surface and Secretome Workflows

  2026-09-02

  Learn how Sulfo-NHS-Biotin converts primary amines into stable biotin handles for cell-surface profiling, affinity workflows, and modular single-cell secretion assays. The guide combines an executable labeling workflow with controls for hydrolysis, background, viability, and antibody-performance failures.

• Tyrothricin: Translating Membrane Disruption

  2026-09-02

  Tyrothricin is more than a broad-spectrum antimicrobial reagent: as a peptide antibiotic mixture, it can serve as a systems-level probe of membrane vulnerability across bacterial, fungal, and exploratory viral models. This thought-leadership perspective connects membrane-focused assay design with mechanistic insights from trigeminal ganglion research to help translational teams build more rigorous infection-control workflows.

• Nuclear mTORC1 and Spatial Transcriptional Control

  2026-09-01

  The reference study introduces TerminaTOR, a genetically encoded inhibitor that can selectively perturb mTORC1 at defined subcellular locations. Its compartment-specific design distinguishes canonical lysosomal signaling from a nuclear mTORC1 function in regulating transcription of CCAAT motif-containing genes, providing a framework for analyzing spatially organized nutrient signaling.

• Chlorpromazine HCl in Neuropharmacology Workflows

  2026-09-01

  Chlorpromazine HCl combines a well-defined dopamine receptor antagonist profile with practical utility in synaptic, hypoxia, and endocytosis assays. This guide shows how to use it as a mechanistic perturbation, pathway comparator, and troubleshooting tool alongside the reference study’s electrical stimulation strategy for nanoparticle uptake.

• Ibuprofen in Colon Cancer Research Workflows

  2026-08-31

  Develop reproducible Ibuprofen workflows for viability, apoptosis, and cell-cycle studies in colon cancer research. This guide combines COX-1 and COX-2 pharmacology with solvent control, serum-binding considerations, and orthogonal assay design to help distinguish genuine anti-proliferative effects from experimental artifacts.

• Chlorpromazine HCl in Macrophage Assays

  2026-08-31

  Chlorpromazine HCl is best evaluated as a mechanistically layered dopamine receptor antagonist in macrophage infection models, not as a simple antibacterial. This guide connects dopamine receptor inhibition with ROS, autophagy, lysosomal activity, and assay controls to improve host-directed therapy research.

• Epacadostat: From IDO1 Potency to Immune Assays

  2026-08-30

  Epacadostat and INCB024360 provide a precise way to interrogate IDO1-driven tryptophan catabolism and immune suppression. This guide explains how to connect biochemical potency with whole-blood, cellular, and tumor-immune readouts without confusing pathway modulation with direct target engagement.

• Phosphatase Inhibitor Cocktail 3: Assay Integrity

  2026-08-29

  Phosphatase Inhibitor Cocktail 3 protects phosphorylation-dependent measurements during lysate preparation. This article explains how K1014 supports phosphoprotein analysis while clarifying what phosphatase inhibition can—and cannot—tell us in botulinum neurotoxin assays.

• p-Cresyl sulfate: CKD Assay Workflows

  2026-08-28

  Build controlled models of uremic toxin exposure with p-Cresyl sulfate, from endothelial repair assays to aortic valve calcification studies. This workflow connects concentration, albumin binding, klotho/SIRT1 signaling, and renal clearance readouts for more interpretable cardiovascular research.

• AMD-070 hydrochloride CXCR4 Assay Workflows

  2026-08-28

  Build more informative CXCR4 experiments with AMD-070 hydrochloride, from chemotaxis and receptor signaling to anti-HIV research. The workflow pairs reversible pharmacology with time-resolved functional readouts, viability controls, and troubleshooting strategies for reproducible translational data.

8049 records 1/537 page Next 12345 下5页 Last page